NCIDEA: DCLG Supplemental Material: Meeting Summary[removed]

First Page		Document Content
Date: 2010-09-21 10:39:14 Cancer organizations Nursing research Clinical research Design of experiments Pharmacology Clinical trial National Cancer Institute National Institutes of Health Cancer research Medicine Health Research		NCIDEA: DCLG Supplemental Material: Meeting Summary[removed] Add to Reading List Source URL: deainfo.nci.nih.gov Download Document from Source Website File Size: 85,38 KB Share Document on Facebook

	Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute DocID: 1vqc4 - View Document
	Checklist for Easy-to-Read Informed Consent Text (Adapted from National Cancer Institute, Bethesda, MD) Words are familiar to the reader or are clearly defined and are used consistently throughout DocID: 1uNbT - View Document
	National Cancer Institute (NCI)/Division of Cancer Treatment and Diagnosis (DCTD) Conflict of Interest Policy for NCI/DCTD-supported Cooperative Group or National Clinical Trials Network Randomized Phase 2 and Phase 3 Cl DocID: 1uHwr - View Document
	Oncology over Internet: integrating data and analysis of oncology interest on the net by means of workflows Paolo Romano () National Cancer Research Institute, Genoa, Italy DocID: 1uuc1 - View Document
	National Cancer Institute Understanding Chemotherapy What is chemotherapy? Chemotherapy is a cancer treatment DocID: 1uhTU - View Document